All dysplastic lesions of the vagina

N14_VAGINAL_DYSPLASIA_ALL

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

941

4. Check minimum number of events

None

941

5. Include endpoints

None

941

6. Filter based on genotype QC (FinnGen only)

941

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4910 4910 -
Only index persons 4706 4706 -
Unadjusted period prevalence (%)
Whole population 0.14 0.14 -
Only index persons 0.17 0.17 -
Median age at first event (years)
Whole population - 50.03 -
Only index persons - 49.20 -

-FinnGen-

Key figures

All Female Male
Number of individuals 941 941 -
Unadjusted period prevalence (%) 0.32 0.32 -
Median age at first event (years) 50.56 50.56 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
828
Matched controls
8280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LEB00
NOMESCO Finland
Biopsy of vagina
97.8
323.0
415
84
ULA02
NOMESCO Finland
Kolposcopy
43.5
323.0
662
695
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
25.2
323.0
579
698
N89.0
ICD-10 Finland
Mild vaginal dysplasia
+∞
323.0
449
*
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
410.6
289.3
275
10
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
+∞
278.3
251
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
12.0
213.1
490
893
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
15.7
212.2
391
447
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
+∞
198.1
182
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
19.5
130.7
206
138
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
12.8
125.9
241
257
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
1212.2
111.2
106
*
LDA10
NOMESCO Finland
Curettage of cervix uteri
11.3
108.3
220
257
A63.0
ICD-10 Finland
Anogenital (venereal) warts
13.5
105.4
194
184
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
16.9
100.4
166
121
N87.1
ICD-10 Finland
Moderate cervical dysplasia
11.6
61.6
119
118
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
11.8
55.0
105
101
N90.0
ICD-10 Finland
Mild vulvar dysplasia
72.9
53.9
61
9
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
18.8
47.7
74
43
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
12.0
41.2
77
70
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
151.0
41.2
43
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
40.0
430
2365
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
14.5
36.4
62
46
N89.3
ICD-10 Finland
Dysplasia of vagina, unspecified
361.9
35.2
35
*
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
99.5
35.0
38
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
18.4
30.4
47
27
ZXC10
NOMESCO Finland
Use of laser
8.6
25.5
56
69
LEB10
NOMESCO Finland
Excision of lesion of vagina
18.4
24.1
37
21
D06BB10
ATC
imiquimod; topical
4.6
22.0
79
185
G01AA10
ATC
clindamycin; vaginal
2.3
20.6
239
1255
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
11.3
20.3
38
35
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
102.4
18.6
20
*
D07.2
ICD-10 Finland
Carcinoma in situ: Vagina
+∞
16.7
16
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.9
16.1
517
3918
ZXC00
NOMESCO Finland
Use of diathermy
12.9
14.4
25
20
6230B
ICD-9 Finland
Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE MODERATA]
+∞
13.6
13
*
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
20.4
12.5
18
9
X86
ICPC
Abnormal cervix smear
7.8
12.5
28
37
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
12.3
120
568
L04AX01
ATC
azathioprine; systemic
3.3
11.5
58
185
D06BB04
ATC
podophyllotoxin; topical
2.8
10.8
70
262
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.2
9.9
104
509
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.0
9.5
137
761
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.2
9.4
20
25
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
2.9
9.1
54
194
C539, 6666, 0
ICD-O-3
NA
5.7
9.1
25
45
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.0
294
2105
L04AA06
ATC
mycophenolic acid; systemic
6.2
9.0
23
38
P01BA02
ATC
hydroxychloroquine; oral
2.2
8.9
93
455
LCA06
NOMESCO Finland
Biopsy of endometrium
1.8
8.7
158
953
N81.6
ICD-10 Finland
Rectocele
2.2
8.5
85
405
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
9.6
8.3
16
17
0781C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]
7.6
8.2
18
24
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
9.0
8.1
16
18
8411
FHL
Local change laser, coagulation, biopsy or removal
18.6
7.6
11
6
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
80.8
7.4
8
*
6230C
ICD-9 Finland
Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE GRAVIS]
+∞
7.3
7
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
7.2
253
1825
R87.0
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal level of enzymes
20.2
7.1
10
5
H02AB06
ATC
prednisolone; systemic
1.5
7.0
364
2861
N89.9
ICD-10 Finland
Noninflammatory disorder of vagina, unspecified
11.0
6.8
12
11
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
40.4
6.8
8
*
LEC00
NOMESCO Finland
Partial excision of vagina
40.4
6.8
8
*
LFC00
NOMESCO Finland
Partial excision of vulva
16.9
6.8
10
6
G01AF01
ATC
metronidazole; vaginal
1.8
6.7
126
764
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
22.7
6.7
9
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.8
6.7
116
687
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
70.4
6.4
7
*
8326
FHL
Batch conization
7.5
6.4
14
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.8
6.3
25
68
N89.5
ICD-10 Finland
Stricture and atresia of vagina
18.2
6.3
9
5
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
6.2
74
385
8325
FHL
Coagulation, cryo or laser in anesthesia or operating room
12.6
6.1
10
8

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
179
187
11.59
158.49
3.6
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
108
48
25.29
150.43
3.9
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
559
2268
4.61
117.69
3.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
227
503
5.63
100.73
3.1
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
588
3642
2.64
44.52
3.8
2.0
—
—
—
0
0
(4035726)
151
711
2.34
18.36
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
149
770
2.11
14.24
4.0
3.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
113
547
2.21
12.69
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
137
715
2.07
12.69
1.8
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
72
303
2.49
11.12
3.8
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
712
6069
1.71
11.09
5.5
4.1
mm/h
12.3
11.4
1.10
660
5644
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
22
7.38
11.01
3.7
2.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
53
197
2.79
10.48
1.5
1.2
u/ml
1.6
5.9
—
5
17
(3005719) IgG [Mass/volume] in Serum or Plasma
113
589
2.04
10.44
3.1
3.0
g/l
10.9
10.2
0.81
105
550
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
162
959
1.83
10.26
3.9
4.1
%
33.1
32.9
0.09
104
657
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
170
1023
1.81
10.20
1.9
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
181
1131
1.74
9.50
2.1
2.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
65
285
2.38
9.20
1.5
1.2
u/ml
5.5
17.8
—
7
19
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
265
1850
1.60
9.04
2.4
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
195
1271
1.67
8.72
1.7
1.3
titre
605.0
564.5
0.13
56
295
(3013115) Eosinophils [#/volume] in Blood
515
4190
1.51
8.59
9.1
5.8
e9/l
0.2
0.2
0.04
472
3732
(3019198) Lymphocytes [#/volume] in Blood
507
4148
1.48
7.99
8.8
5.5
e9/l
1.9
2.0
0.26
470
3703
(3028026) IgM [Mass/volume] in Serum or Plasma
87
457
2.00
7.86
1.8
1.8
g/l
1.3
1.4
0.10
78
423
(3001604) Monocytes [#/volume] in Blood
493
4019
1.48
7.86
8.9
5.5
e9/l
0.5
0.5
0.16
449
3527
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
455
3659
1.47
7.73
2.8
2.3
nmol/l
78.4
78.0
0.13
410
3335
(3004616) Nuclear Ab [Presence] in Serum
34
118
2.95
7.65
1.8
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
58
265
2.27
7.50
1.6
1.2
u/ml
10.2
11.1
0.05
15
54
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
57
259
2.28
7.47
1.6
1.2
u/ml
9.3
1.9
0.60
13
29
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
113
662
1.80
7.33
6.4
4.4
u/l
241.8
257.3
0.36
105
628
(3044640) Blood type and Crossmatch panel - Blood
326
2477
1.48
7.27
2.5
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
422
3372
1.46
7.26
6.7
5.1
mmol/l
1.2
1.2
1.02
367
3060
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
122
2.85
7.23
9.7
4.4
iu/ml
474.0
154.8
—
9
13
(3006315) Basophils [#/volume] in Blood
491
4040
1.45
7.22
8.9
5.5
e9/l
0.0
0.0
0.34
447
3540
(3024561) Albumin [Mass/volume] in Serum or Plasma
401
3181
1.45
7.13
5.8
4.1
g/l
36.2
36.2
0.04
368
2970
(3006504) Eosinophils/100 leukocytes in Blood
460
3769
1.43
6.75
8.6
5.6
%
2.7
2.7
0.00
432
3514
(3019069) Monocytes/100 leukocytes in Blood
461
3785
1.43
6.65
9.0
5.9
%
8.2
8.1
0.14
432
3554
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
45
4.06
6.64
1.7
2.0
e6/l
795.4
819.0
—
8
18
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
458
3757
1.43
6.63
8.0
5.8
mmol/l
1.2
1.2
0.15
388
3167
(3022096) Basophils/100 leukocytes in Blood
445
3643
1.42
6.46
8.6
5.7
%
0.7
0.7
0.01
415
3395
(3002030) Lymphocytes/100 leukocytes in Blood
472
3907
1.42
6.42
8.7
5.7
%
29.7
29.3
0.37
440
3652
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
25
81
3.14
6.35
1.4
1.1
u/ml
45.6
76.1
—
5
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
464
3838
1.41
6.29
3.9
3.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
466
3863
1.41
6.21
8.6
5.4
%
56.0
56.6
0.57
437
3623
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
240
2.19
6.18
2.1
2.1
g/l
1.4
1.5
0.41
43
210
(3007164) IgA [Mass/volume] in Serum or Plasma
235
1720
1.49
6.15
1.5
1.5
g/l
2.2
2.2
0.02
143
1050
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
693
6173
1.47
6.11
10.0
6.8
u/l
74.8
75.4
0.19
661
5798
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
137
890
1.63
6.09
7.6
5.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
331
2591
1.43
6.08
8.4
5.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
55
3.51
5.75
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
241
1800
1.46
5.63
4.9
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
229
1697
1.46
5.57
1.6
1.5
nmol/l
21.6
22.0
0.15
194
1464
(3003458) Phosphate [Moles/volume] in Serum or Plasma
127
836
1.60
5.34
8.3
4.4
mmol/l
1.1
1.0
0.13
118
759
(3037467) Urinalysis macro (dipstick) panel - Urine
631
5595
1.39
5.18
5.9
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
324
2588
1.38
5.10
3.2
3.2
ng/l
24.6
41.8
0.52
182
1537
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
103
653
1.65
5.04
3.1
2.0
g/l
0.2
0.2
0.23
98
620
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
23
4.83
5.02
1.5
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
23
4.83
5.02
1.5
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
543
4714
1.36
5.00
12.0
8.6
e9/l
3.8
3.9
0.95
491
4164
(3045424) Erythrocytes [Presence] in Urine
31
132
2.39
4.78
1.3
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
27
108
2.54
4.74
1.9
2.9
%
1.3
1.5
0.12
21
84
(3019309) Folate [Moles/volume] in Red Blood Cells
172
1241
1.47
4.74
1.7
1.7
nmol/l
1098.3
1231.1
1.22
133
938
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
370
3046
1.35
4.74
2.0
1.9
pmol/l
101.0
99.3
0.23
183
1503
(3007853) Bacteria identified in Skin by Aerobe culture
124
835
1.56
4.73
1.7
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
19
63
3.06
4.69
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
159
1132
1.49
4.68
2.6
2.1
ug/g
143.0
101.6
0.54
116
879
(3020779) Urea [Moles/volume] in Serum or Plasma
80
486
1.71
4.61
11.1
6.6
mmol/l
9.0
8.0
0.78
75
462
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
159
1137
1.48
4.58
3.4
2.4
e6/l
1.2
1.2
0.03
96
608
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
98
2.59
4.58
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
64
3.01
4.57
2.4
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
189
1398
1.44
4.57
1.6
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
263
2062
1.38
4.55
1.3
1.3
u/ml
1.2
1.6
0.25
67
554
(40768446) Kidney Pathology biopsy report
10
21
4.80
4.54
2.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
30
4.04
4.44
1.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
150
1068
1.48
4.41
2.0
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
927
1.51
4.34
1.6
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
107
713
1.56
4.28
2.9
3.1
u/ml
28.8
51.9
1.43
102
687
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
31
3.91
4.26
1.5
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
293
1.86
4.20
2.1
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
49
264
1.90
4.20
2.0
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
62
2.94
4.19
1.6
2.2
e9/l
1.6
1.2
—
9
40
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
216
1.99
4.12
1.6
1.2
u/ml
43.2
47.7
0.08
12
20
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
242
1908
1.36
3.98
2.6
2.1
mg/l
2.7
3.0
1.33
204
1635
(40761535) Cells panel - Urine sediment
89
580
1.59
3.93
5.1
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
31
146
2.16
3.84
1.9
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
215
1.95
3.83
4.0
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
114
2.32
3.81
1.4
1.6
g/l
0.5
0.8
0.60
21
93
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
118
828
1.49
3.73
4.3
2.3
umol/l
6.7
5.9
0.23
106
706
(46235355) HIV 1 and 2 tests - Meaningful Use set
211
1644
1.37
3.72
1.9
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
296
2431
1.32
3.66
3.4
2.3
u/l
55.5
55.7
0.04
279
2241
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
74
470
1.62
3.64
1.8
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
35
3.46
3.62
4.2
2.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
77
495
1.61
3.61
1.8
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
92
618
1.54
3.57
1.2
1.3
u/ml
135.1
208.9
0.73
87
577
(3009261) Glucose [Presence] in Urine by Test strip
465
4065
1.28
3.55
4.5
3.5
estimate
0.0
0.0
0.80
77
750
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
348
1.71
3.54
1.6
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
489
4303
1.28
3.54
4.8
4.1
mmol/l
6.5
6.5
0.00
455
3968
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
143
1052
1.42
3.54
3.7
2.5
e6/l
4.6
4.5
0.04
79
525
(3021879) Hepatitis B virus core Ab [Presence] in Serum
89
595
1.55
3.53
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
305
2526
1.31
3.52
3.4
2.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
93
2.40
3.50
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
94
2.37
3.43
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
94
2.37
3.43
1.4
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
33
167
2.01
3.42
3.7
3.9
mg/l
35.3
26.0
0.48
33
132
(3034860) Kappa light chains.free [Mass/volume] in Serum
33
167
2.01
3.42
3.7
3.9
mg/l
35.7
35.4
0.02
33
134
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
174
1.99
3.42
1.5
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
74
478
1.59
3.41
3.5
2.5
e9/l
73.2
75.2
0.20
58
357
(3021601) Nitrite [Presence] in Urine by Test strip
460
4029
1.28
3.41
5.9
4.8
estimate
0.0
0.0
0.50
75
760
(3051611) Lipemic interference index of Serum or Plasma
17
64
2.69
3.41
3.9
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
270
2211
1.31
3.37
2.4
2.1
u/l
107.7
171.4
1.42
256
2087
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
96
2.32
3.28
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
122
2.16
3.28
1.7
1.3
u/ml
116.3
123.2
—
8
28
(36660697) Celiac disease serology panel - Serum
104
731
1.48
3.27
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
455
3994
1.27
3.26
4.5
3.5
estimate
0.0
0.0
0.00
70
758
(3000991) Gas panel - Venous blood
72
468
1.58
3.24
9.0
7.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
97
2.30
3.21
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
97
2.30
3.21
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
15
5.37
3.19
1.6
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
137
2.08
3.19
1.6
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
150
1134
1.38
3.17
4.2
2.9
mmol/l
0.8
0.8
0.74
139
1060
(3030467) Casts [#/volume] in Urine by Automated count
239
1942
1.31
3.13
4.0
2.8
e6/l
0.3
0.4
0.32
180
1430
(3009508) Creatinine [Moles/volume] in Urine
262
2160
1.30
3.07
3.4
3.0
mmol/l
6.5
6.8
0.71
217
1840
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
29
3.47
3.05
1.3
1.2
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
5
5
10.04
2.98
5.4
2.0
mg/l
3.9
4.5
—
5
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
40
3.03
2.98
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
114
2.13
2.96
1.6
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
237
1937
1.30
2.96
3.9
2.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
88
2.30
2.95
2.3
1.9
mg/l
19.8
19.8
—
8
26
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
46
2.85
2.92
1.5
1.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
13
46
2.85
2.92
1.2
1.2
titre
104.0
88.6
—
5
7
(3004789) Transferrin [Mass/volume] in Serum or Plasma
134
1008
1.38
2.92
3.3
2.1
g/l
2.3
2.4
1.32
123
932
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
64
2.53
2.88
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
64
2.53
2.88
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
58
370
1.60
2.85
1.8
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
455
4043
1.24
2.78
7.8
5.4
umol/l
9.2
10.0
1.50
439
3810
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
6
8.37
2.75
7.6
3.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
320
2736
1.26
2.75
3.1
3.3
mmol/l
2.4
2.4
0.02
268
2431
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
122
915
1.38
2.71
3.5
2.2
%
24.0
22.8
0.51
108
774
(3015171) Extractable nuclear Ab [Units/volume] in Serum
60
391
1.57
2.71
1.5
1.3
u/ml
2.6
1.1
—
5
34
(40768443) Skin Pathology biopsy report
53
339
1.60
2.60
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
253
1.69
2.59
1.6
1.6
iu/ml
0.0
0.1
—
9
37
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
25
3.62
2.58
1.2
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
20
4.03
2.57
1.6
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
848
8150
1.41
2.56
16.4
11.9
mg/l
17.9
19.6
0.92
674
6280
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
211
1729
1.28
2.56
3.0
2.8
ng/l
630.9
878.5
1.53
178
1441
(3002582) Erythrocytes [#/volume] in Urine
254
2130
1.26
2.55
4.2
2.9
e6/l
27.8
50.1
1.07
195
1599
(40758558) Short blood count panel - Blood
248
2076
1.26
2.52
8.8
6.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
165
1.85
2.51
1.3
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
185
1494
1.30
2.51
3.1
2.4
e6/l
8.1
8.2
0.01
159
1311
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
69
2.34
2.49
2.1
1.4
g/l
1.0
1.0
0.07
16
69
(3027945) Reticulocytes/100 erythrocytes in Blood
91
659
1.42
2.49
3.8
2.7
%
2.0
1.9
0.71
78
585
(3013512) EKG study
249
2089
1.26
2.48
3.6
3.3
—
—
—
0
0
(4034850)
41
249
1.68
2.47
7.4
7.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
251
2110
1.26
2.46
5.1
3.9
estimate
0.0
0.0
1.08
73
763
(3026493) Urate [Moles/volume] in Serum or Plasma
225
1867
1.27
2.46
3.5
2.3
umol/l
313.9
4974.4
6.30
199
1636
(40768441) Liver Pathology biopsy report
14
57
2.48
2.45
2.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
804
7673
1.33
2.45
12.6
10.7
ml/min/173m2
84.0
84.6
0.31
667
6269
(3022145) Colonoscopy Study observation
119
907
1.36
2.41
1.5
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
82
588
1.43
2.37
2.8
2.8
e9/l
4.3
4.1
0.40
68
480
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
87
631
1.42
2.37
3.3
3.3
pmol/l
4.5
4.5
0.18
78
556
(3019150) Specific gravity of Urine by Refractometry
206
1703
1.27
2.31
5.5
3.9
kg/l
1.0
1.0
0.59
17
248
(3025159) Blasts/100 leukocytes in Blood
83
600
1.42
2.31
5.0
4.0
%
0.0
1.4
0.85
28
125
(3000093) Morphology [Interpretation] in Blood Narrative
13
53
2.47
2.28
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
13
4.64
2.27
4.2
3.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
852
8220
1.39
2.27
15.9
12.7
mmol/l
139.6
139.7
0.32
825
7999
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
818
7845
1.33
2.25
4.5
4.2
mmol/l
5.7
5.8
1.93
740
7247
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
596
1.41
2.22
4.9
3.2
ng/l
117.8
75.4
2.06
72
529
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
80
2.15
2.19
1.5
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
25
136
1.86
2.19
1.4
1.5
ug/l
1.9
3.4
0.82
18
117
(3023103) Potassium [Moles/volume] in Serum or Plasma
853
8238
1.38
2.19
16.2
12.8
mmol/l
3.9
3.9
0.01
823
7998
(3018095) Leukocytes [#/volume] in Urine
303
2630
1.22
2.19
4.9
3.4
e6/l
65.2
68.5
0.05
209
1745
(3023368) Bacteria identified in Blood by Culture
201
1668
1.26
2.18
4.9
3.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
888
8638
1.50
2.18
13.3
9.6
u/l
23.7
23.6
0.06
859
8371
(3017181) Myelocytes/100 leukocytes in Blood
90
668
1.38
2.16
4.8
3.9
%
0.6
1.0
1.14
35
169
(3004588) Protein electrophoresis panel - Serum or Plasma
64
447
1.46
2.15
2.1
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
43
2.58
2.10
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
234
1986
1.24
2.08
3.5
3.2
mg/l
64.2
257.4
1.44
123
1169
(4062490)
16
76
2.12
2.03
1.4
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
139
1112
1.29
2.03
3.5
2.2
umol/l
13.1
13.5
0.30
124
1023
(3002385) Erythrocyte distribution width [Ratio]
659
6963
0.82
2.02
18.4
14.4
%
13.6
13.6
0.08
646
6813
(3017569) Oxygen content in Arterial blood
8
26
3.09
2.01
5.8
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
133
1.83
2.01
4.4
4.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
101
774
1.34
2.00
2.3
2.0
nmol/l
378.2
375.3
0.05
90
718
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
148
1.78
2.00
1.6
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
192
1603
1.25
1.98
1.5
1.6
pmol/l
27059268.0
30752653.1
0.04
170
1356
(3002256) Pathology report gross observation
136
1089
1.29
1.97
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
51
347
1.50
1.96
1.4
1.3
miu/ml
174.9
230.2
0.53
27
174
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
91
2.00
1.96
2.9
2.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
33
203
1.65
1.94
1.5
1.4
u/l
26.2
27.5
0.07
24
167
(3022689) Creatine [Moles/volume] in Urine
6
16
3.77
1.93
1.3
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
922
9065
1.85
1.93
23.7
17.9
e9/l
268.0
265.9
0.46
902
8877
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
33
2.74
1.93
1.7
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
85
638
1.37
1.93
5.0
3.9
%
0.0
0.1
1.68
32
156
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
212
1.63
1.91
1.4
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
121
1.84
1.89
1.3
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
922
9068
1.83
1.88
23.6
17.9
fl
91.1
90.8
1.69
911
8960
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
23
129
1.80
1.87
1.4
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
18
93
1.95
1.86
1.4
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
922
9070
1.82
1.85
23.7
17.9
e12/l
4.4
4.4
2.08
901
8855
(3035941) MCH [Entitic mass]
922
9070
1.82
1.85
23.6
17.8
pg
30.3
30.1
2.54
911
8961
(3010813) Leukocytes [#/volume] in Blood
922
9072
1.81
1.82
23.7
18.0
e9/l
6.7
6.6
0.09
901
8857
(3020682) Albumin/Creatinine [Ratio] in Urine
242
2089
1.21
1.81
4.1
3.8
mg/mmol
13.0
7.8
0.59
127
1225
(3000963) Hemoglobin [Mass/volume] in Blood
922
9073
1.80
1.80
23.8
18.0
g/l
132.0
132.7
1.08
910
8968
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
161
1.70
1.80
3.0
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
81
611
1.36
1.79
4.7
3.7
%
0.4
0.7
1.14
25
120
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
29
2.77
1.79
1.0
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
29
2.77
1.79
1.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
60
2.18
1.78
2.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
60
2.18
1.78
2.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
60
2.18
1.78
2.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
96
745
1.32
1.77
25.5
19.5
inr
1.2
1.2
0.01
15
114
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
41
2.45
1.76
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
41
2.45
1.76
1.0
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
165
1375
1.24
1.73
3.5
2.5
mosm/kgh2o
485.6
514.4
1.00
141
1165
(3032080) INR in Blood by Coagulation assay
298
2637
1.19
1.70
7.0
7.3
inr
1.2
1.1
0.27
68
820
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
164
1369
1.24
1.70
2.6
2.6
mmol/l
2.4
2.4
0.06
140
1212
(3008037) Lactate [Moles/volume] in Venous blood
6
145
0.41
1.65
2.7
2.6
mmol/l
1.2
1.4
—
6
140
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
69
515
1.37
1.65
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
49
2.26
1.64
2.3
2.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
14
3.58
1.61
1.6
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
273
3074
0.84
1.61
2.3
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
92
720
1.31
1.61
1.9
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
63
2.08
1.60
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
63
2.08
1.60
1.8
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
588
5522
1.17
1.59
3.6
2.9
u/l
47.3
39.3
0.77
555
5201
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
7
26
2.70
1.58
1.1
1.2
pmol/l
455.3
366.6
—
7
18
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
193
1652
1.21
1.57
1.4
1.3
u/ml
10.2
13.1
0.26
75
673
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
92
725
1.30
1.54
1.9
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
33
2.44
1.54
5.8
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
116
942
1.26
1.53
1.5
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
27
2.60
1.51
1.6
2.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
27
2.60
1.51
1.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
184
0.48
1.51
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
267
1.48
1.51
4.6
3.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
21
2.87
1.50
1.7
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
45
0.00
1.50
0.0
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
58
2.08
1.49
1.0
1.1
mg/l
300.8
297.6
0.08
12
50
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
139
1.67
1.49
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
139
1.67
1.49
1.5
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
227
1.52
1.48
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
28
2.51
1.45
3.1
2.1
ug/l
43.3
47.8
—
7
28
(40761511) CBC panel - Blood by Automated count
877
8574
1.34
1.45
14.2
11.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
16
3.14
1.44
1.4
2.8
umol/l
16.8
19.3
—
5
16
(3011436) Histone Ab [Units/volume] in Serum
5
16
3.14
1.44
1.2
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
22
2.74
1.43
1.5
7.0
mg/l
58.7
79.1
—
6
14
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
81
635
1.30
1.42
2.3
2.3
ml/min/173m2
68.8
72.0
0.23
30
250
(3025941) Bacteria identified in Stool by Culture
64
485
1.34
1.42
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
53
708
0.73
1.40
4.0
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
429
3959
1.15
1.39
3.3
2.8
ug/l
92.8
81.4
0.86
401
3696
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
829
8057
1.24
1.37
4.4
4.1
mmol/l
4.9
4.9
0.30
769
7570
(3048929) Epstein Barr virus Ab [Presence] in Serum
36
248
1.47
1.37
1.6
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
23
2.62
1.37
1.7
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
135
1.64
1.36
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
840
8183
1.25
1.31
4.8
4.5
mmol/l
2.9
2.9
0.21
769
7631
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
24
2.51
1.30
4.2
1.9
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
9
43
2.10
1.30
2.9
1.8
nmol/l
1.3
1.4
—
9
38
(40765096) Chromosome analysis panel by Banding
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
71
556
1.30
1.28
6.1
2.9
mmol/l
1.3
2.2
1.16
63
447
(40768797) Stomach Pathology biopsy report
139
1178
1.21
1.27
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
252
2250
1.16
1.26
5.9
3.5
ph
7.4
7.4
0.05
39
440
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
131
1.62
1.24
1.0
1.0
u/ml
0.9
2.2
—
5
41
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
470
1.32
1.24
2.5
2.2
ug/l
4.1
6.1
0.96
48
421
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
63
1.92
1.23
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
63
1.92
1.23
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
38
272
1.41
1.21
4.0
2.2
%
0.6
0.7
0.33
38
261
(3000330) Specific gravity of Urine by Test strip
24
358
0.66
1.20
5.0
3.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.84
1.20
1.8
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
36
256
1.42
1.19
1.1
1.1
u/ml
1.9
5.9
—
5
37
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
297
2697
1.15
1.18
4.4
2.8
u/l
30.7
28.6
0.67
287
2579
(3049717) Cytology report of Urine Cyto stain
26
174
1.51
1.16
1.9
2.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
39
2.06
1.15
1.1
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
397
1.33
1.14
1.8
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
383
3548
1.13
1.12
10.8
8.6
e9/l
0.0
0.0
0.20
317
2920
(3020630) Protein [Mass/volume] in Serum or Plasma
66
523
1.28
1.11
2.5
2.8
g/l
67.4
67.5
0.03
57
486
(3006653) Thiamine [Moles/volume] in Blood
7
31
2.27
1.10
1.0
1.6
nmol/l
124.7
147.9
—
7
31
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
104
1.65
1.10
1.1
1.3
nmol/l
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
120
1.60
1.09
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
32
2.20
1.08
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
32
2.20
1.08
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
107
900
1.21
1.07
1.9
1.6
%
1.3
1.3
0.51
93
808
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
129
1.56
1.06
1.9
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
237
1.41
1.06
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
106
1.61
1.03
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
239
1.39
1.01
1.4
1.4
ug/g
306.0
302.2
0.03
21
128
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
191
1700
1.15
1.00
1.4
1.3
iu/ml
21.4
29.8
1.07
59
568
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
35
257
1.38
1.00
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
35
257
1.38
1.00
1.3
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
337
3117
1.13
0.99
4.8
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
211
1897
1.14
0.96
1.7
1.7
mg/l
0.9
0.9
0.04
154
1436
(3020891) Body temperature
33
242
1.38
0.96
5.6
4.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
222
0.63
0.95
1.5
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
303
1.33
0.95
7.6
9.3
mmol/l
23.8
24.4
0.79
34
285
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
51
1.77
0.94
1.3
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
118
0.51
0.94
3.5
6.4
umol/l
277.5
377.2
—
6
103
(4268621)
15
93
1.62
0.94
2.1
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
751
7296
1.15
0.92
5.3
5.1
mmol/mol
38.3
38.9
1.28
687
6831
(42529406) Shigella sp [Presence] in Stool by Culture
35
261
1.35
0.92
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
358
1.30
0.92
4.0
3.2
mmol/l
1.5
2.0
0.38
34
275
(44806118)
13
78
1.68
0.92
1.4
1.4
—
—
—
0
0
(44790049)
13
78
1.68
0.92
1.4
1.4
—
—
—
0
0
(44790048)
13
78
1.68
0.92
1.4
1.4
—
—
—
0
0
(44790047)
13
78
1.68
0.92
1.4
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
236
1.37
0.91
2.8
1.9
g/l
2.9
3.1
0.69
27
195
(1761482) Bacteria [#/volume] in Urine by Culture
10
170
0.58
0.90
4.9
4.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
205
1851
1.14
0.88
1.6
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
246
1.35
0.88
2.8
1.9
g/l
3.6
3.7
0.31
27
192
(3042936) Bacteria identified in Isolate by Culture
117
1015
1.17
0.86
2.1
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
247
1.35
0.86
2.8
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
247
1.35
0.86
2.8
1.9
g/l
7.6
7.6
0.00
27
203
(3045142) Bone marrow Pathology biopsy report
11
64
1.73
0.86
1.1
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
112
1.53
0.85
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(4010399)
67
553
1.23
0.84
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
45
1.78
0.84
3.0
1.8
%
9.4
10.1
—
8
45
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
57
1.76
0.84
6.3
1.6
ug/l
40.3
7.7
—
10
46
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
373
1.27
0.83
4.1
3.3
kpa
5.1
5.2
0.14
42
356
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
46
1.75
0.82
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
138
1.46
0.82
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
232
1.35
0.82
3.1
2.9
u/ml
18.2
734.6
0.66
24
202
(3009871) Measles virus Ab [Titer] in Serum
6
32
1.88
0.82
1.7
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
716
6955
1.12
0.80
4.8
4.4
pmol/l
14.6
14.6
0.22
663
6473
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
147
1.44
0.80
1.1
1.2
u/ml
1.4
1.9
—
5
44
(3029396) Erythrocyte agglutination [Presence] in Blood
0
25
0.00
0.79
0.0
3.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
818
8016
1.16
0.79
4.4
4.1
mmol/l
1.6
1.6
0.01
749
7494
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
131
1.46
0.78
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
47
376
1.26
0.78
4.0
2.7
g/l
125.7
127.6
0.30
47
365
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
41
323
1.28
0.77
1.3
1.5
pmol/l
159.9
200.7
0.19
41
316
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
34
1.77
0.76
2.5
3.3
u/ml
4568.3
634.7
—
6
34
(3027456) Digoxin [Moles/volume] in Serum or Plasma
15
99
1.52
0.76
2.9
3.3
nmol/l
0.8
0.8
—
10
80
(3005082) Progesterone [Moles/volume] in Serum or Plasma
9
53
1.70
0.75
1.2
1.2
nmol/l
25.3
30.0
—
9
38
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
227
1.33
0.75
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
75
1.61
0.75
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
116
1.47
0.74
1.1
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
108
1.49
0.74
1.1
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
711
1.18
0.73
3.3
2.2
u/l
97.9
37.4
0.69
74
594
(3000764) Benzodiazepines [Presence] in Urine
38
299
1.28
0.73
2.3
1.5
—
—
—
0
0
(4198724)
5
25
2.01
0.72
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
92
1.53
0.72
2.2
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
56
1.61
0.72
4.4
7.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
213
1954
1.12
0.72
6.5
4.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
26
1.93
0.70
1.8
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
301
1.27
0.70
2.3
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
41
1.71
0.70
1.0
1.1
u/l
60.7
84.5
—
7
33
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
58
1.56
0.70
2.8
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
118
1.45
0.69
1.1
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
2.6
2.2
mg/l
9.6
9.5
—
5
22
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
42
1.67
0.68
2.0
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
44
357
1.24
0.67
2.1
2.1
u/l
42.3
40.0
0.35
38
316
(3004716) Salmonella sp identified in Stool by Organism specific culture
61
513
1.20
0.67
1.8
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
94
1.50
0.67
2.1
1.7
%
60.7
59.4
0.08
14
94
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
155
0.64
0.66
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
145
1.39
0.66
1.1
1.2
u/ml
2.6
5.0
—
7
52
(3003396) Base excess in Arterial blood by calculation
80
693
1.17
0.64
5.8
7.2
mmol/l
0.8
1.4
0.86
59
551
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
29
1.73
0.64
1.8
1.4
ug/l
7.9
8.2
—
5
29
(3024928) Oxygen saturation in Venous blood
18
129
1.40
0.63
2.2
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
243
1.29
0.63
2.9
3.0
g/l
0.4
0.3
0.10
12
72
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
155
1.36
0.63
3.7
3.2
u/ml
0.2
0.4
—
9
85
(3019832) Treponema pallidum Ab [Presence] in Serum
107
950
1.14
0.62
1.4
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
44
532
0.82
0.62
1.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
39
316
1.24
0.62
1.5
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
253
1.27
0.61
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
130
1.39
0.61
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
45
371
1.22
0.61
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
600
5814
1.09
0.61
3.3
3.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
20
0.00
0.60
0.0
1.8
—
5.8
—
0
13
(3027008) Opiates [Presence] in Urine
37
299
1.25
0.60
2.4
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
122
1.40
0.60
1.1
1.0
u/ml
1.2
4.1
—
6
40
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
21
0.00
0.60
0.0
5.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
72
1.53
0.59
1.5
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
6
35
1.72
0.57
2.8
2.2
ug/l
3.7
3.3
—
6
29
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
786
7718
1.11
0.57
4.0
3.7
mmol/l
1.3
1.2
0.58
708
7172
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
687
0.85
0.57
1.4
1.3
iu/l
37.4
29.8
0.76
49
588
(3022806) Fractional oxyhemoglobin in Capillary blood
5
88
0.57
0.56
1.4
1.9
%
88.1
90.1
—
5
88
(1001926) Buprenorphine [Presence] in Urine by Screen method
30
239
1.26
0.56
2.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
251
0.75
0.55
1.3
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
37
1.63
0.55
1.5
1.3
—
68.0
—
0
5
(3045716) Anion gap in Serum or Plasma
6
37
1.63
0.55
7.2
1.9
mmol/l
9.3
9.1
—
6
30
(3016879) Cocaine [Presence] in Urine
34
276
1.24
0.54
2.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
71
619
1.16
0.54
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
82
1.47
0.54
1.4
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
250
0.76
0.54
1.3
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
38
1.58
0.54
2.3
2.1
ug/l
23.7
232.3
—
6
33
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
79
695
1.15
0.54
5.9
7.2
kpa
5.1
5.1
0.12
74
670
(3027801) Oxygen [Partial pressure] in Arterial blood
79
695
1.15
0.54
5.9
7.2
kpa
14.3
12.7
1.03
73
667
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
801
7880
1.11
0.53
5.6
5.2
mu/l
1.7
2.0
0.84
739
7367
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
65
1.39
0.50
1.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
16
118
1.36
0.50
1.1
1.3
—
0.5
—
0
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.3
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.3
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.3
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
119
1.35
0.48
1.8
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
177
0.73
0.47
2.4
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
68
1.48
0.47
1.1
1.1
—
—
—
0
0
(44813793)
10
68
1.48
0.47
1.1
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
772
7594
1.09
0.47
15.4
12.8
%
39.4
39.3
0.27
577
5770
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
320
0.81
0.46
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
292
1.21
0.45
2.2
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
164
0.73
0.45
3.4
3.5
e9/l
4.5
4.2
0.21
12
164
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
149
1.28
0.42
2.7
2.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
260
0.80
0.40
1.2
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
34
1.47
0.40
1.4
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
60
1.34
0.40
3.1
3.6
—
—
—
0
0
(4024509)
10
71
1.41
0.39
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
537
0.87
0.39
2.7
2.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
178
1.24
0.39
1.2
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
301
0.83
0.38
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
301
0.83
0.38
1.2
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
67
1.35
0.38
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
31
365
0.84
0.37
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
300
0.83
0.37
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
300
0.83
0.37
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
169
0.77
0.37
3.5
3.8
%
62.2
58.1
0.49
13
169
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
168
0.77
0.36
1.0
1.1
u/ml
6.7
2.7
—
5
75
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
76
0.66
0.36
1.2
1.6
—
—
—
0
0
(4094501)
15
190
0.79
0.36
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
208
1.21
0.35
3.3
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
66
731
0.90
0.35
3.2
3.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
43
1.40
0.35
1.2
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
319
0.84
0.34
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
50
445
1.13
0.33
2.0
2.1
u/l
1089.7
3204.4
0.93
16
182
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
108
1004
1.09
0.32
2.0
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
110
1.28
0.32
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
107
0.75
0.29
1.4
2.4
—
—
—
0
0
(3036603) Volume of Urine
7
57
1.23
0.29
1.6
1.4
—
2518.4
—
0
8
(3027273) Bicarbonate [Moles/volume] in Venous blood
34
298
1.15
0.28
4.7
2.9
mmol/l
25.0
25.7
0.90
34
288
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
151
0.79
0.28
1.3
1.9
g/l
137.8
131.7
—
6
110
(3036489) Thrombin time
34
299
1.14
0.27
2.6
1.9
s
23.5
20.6
1.64
29
259
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
258
0.85
0.27
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
54
593
0.91
0.27
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
405
0.88
0.26
2.9
4.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.4
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
72
0.69
0.26
1.8
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
77
714
1.09
0.26
3.9
3.8
ug/l
3.3
9.3
3.02
62
565
(1616796) Gas panel - Central venous blood
11
138
0.79
0.25
2.2
2.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
476
1.10
0.23
2.8
2.6
ng/l
108.5
147.1
1.09
46
439
(4281824)
10
125
0.80
0.23
1.2
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
39
1.28
0.23
1.4
1.1
u/l
83.6
510.8
—
5
34
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
125
1314
0.94
0.22
3.2
3.3
ng/l
157.0
324.4
0.87
84
883
(3006462) Nitrate [Presence] in Urine
5
41
1.22
0.22
2.2
3.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
50
459
1.09
0.21
1.1
1.1
—
202.8
—
0
9
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
79
842
0.93
0.21
1.9
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
11
0.00
0.21
0.0
2.0
—
1.2
—
0
11
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.4
—
0.2
—
0
10
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
98
1.23
0.21
1.3
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
7
(3001019) Free T4 and TSH panel - Serum or Plasma
73
683
1.07
0.21
1.9
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
0.6
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
136
1.18
0.20
2.5
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
155
1.16
0.20
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
155
1.16
0.20
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
52
1.15
0.19
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
52
1.15
0.19
2.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
109
1.20
0.18
1.2
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
100
1.20
0.18
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
59
1.19
0.18
1.9
1.3
—
62.3
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
7
61
1.15
0.17
2.4
1.9
—
—
—
0
0
(4027681)
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
39
360
1.09
0.16
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
92
1.20
0.16
1.4
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
222
2279
0.97
0.16
3.4
3.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
80
0.75
0.15
1.8
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
140
1.15
0.15
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
557
5507
1.03
0.14
3.7
3.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
83
1.09
0.14
1.6
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
116
0.86
0.12
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
147
0.88
0.11
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
172
1.11
0.11
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
126
0.87
0.11
1.5
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
368
1.06
0.10
1.4
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
197
0.91
0.10
1.4
1.6
—
—
—
0
0
(4306422)
15
135
1.11
0.09
1.3
1.1
—
—
—
0
0
(4211845)
5
46
1.09
0.09
2.2
3.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.6
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
12
134
0.89
0.08
1.2
1.1
%
118.5
119.5
0.04
12
125
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
185
1.08
0.08
1.1
1.1
u/ml
0.5
2.0
—
6
71
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
38
399
0.95
0.08
2.9
2.4
—
—
—
0
0
(4146454)
6
70
0.86
0.07
4.3
2.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
78
1.03
0.07
1.5
1.6
pg
33.4
31.5
—
8
78
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
82
0.85
0.07
2.4
1.3
nmol/l
1.2
1.9
—
7
67
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
89
1.12
0.07
1.1
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
89
1.12
0.07
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
104
0.86
0.06
1.6
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
41
394
1.04
0.06
1.5
1.7
mg/l
2.2
4.4
0.78
31
272
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
100
980
1.02
0.05
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
314
0.95
0.05
7.3
10.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
92
901
1.02
0.05
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
263
0.95
0.05
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
228
2304
0.99
0.05
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
120
1.08
0.05
1.5
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
140
1.07
0.04
3.5
1.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
11
101
1.09
0.04
1.1
1.1
%
96.1
94.0
0.20
11
96
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
215
2167
0.99
0.03
1.7
1.6
mmol/l
1.3
1.3
0.17
188
1862
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
189
0.95
0.03
1.3
1.5
e6/l
71.2
11.4
0.67
12
149
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
189
0.95
0.03
1.3
1.6
e6/l
281.6
410.9
0.16
12
156
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
262
1.03
0.02
2.1
1.9
iu/l
2.9
5.1
1.51
11
101
(1617658) Protocol used for examination of sentinel lymph nodes
11
117
0.94
0.01
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
183
1.04
0.01
2.1
2.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
101
1002
1.01
0.01
2.6
1.9
s
28.9
29.4
0.52
101
971
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
164
1.04
0.00
1.8
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
336
0.98
0.00
1.5
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
136
1.03
0.00
1.7
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
146
1.03
0.00
1.1
1.0
u/ml
3.0
2.8
—
7
72
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
118
1.02
0.00
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
192
0.99
0.00
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
77
772
1.00
0.00
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
307
1.01
0.00
2.3
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
78
775
1.01
0.00
1.2
1.2
iu/ml
94.5
146.1
1.12
28
319
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
9.6
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
96
0.94
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
53
0.94
0.00
1.4
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
69
0.87
0.00
1.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
72
0.97
0.00
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
6.5
—
0
8
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
73
0.96
0.00
2.3
2.8
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
4.1
—
0
9
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint N14_VAGINAL_DYSPLASIA_ALL and mortality.

Females

Parameter HR [95% CI] p-value
N14_VAGINAL_DYSPLASIA_ALL 1.242 [1.1, 1.41] < 0.001
Birth year 0.995 [0.99, 1.0] 0.289

During the follow-up period (1.1.1998 — 31.12.2019), 449 out of 4114 females with N14_VAGINAL_DYSPLASIA_ALL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VAGINAL_DYSPLASIA_ALL.

N-year risk Females Males
1 0.054% No data
5 0.636% No data
10 1.703% No data
15 3.337% No data
20 6.267% No data

Relationships between endpoints

Index endpoint: N14_VAGINAL_DYSPLASIA_ALL – All dysplastic lesions of the vagina

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data